Recently, mutations in the enzyme cytosolic isocitrate dehydrogenase (IDH1) were discovered to inhibit STAT1 signaling to induce CD8+ T cell accumulation, thereby promoting immune evasion in gliomas (26). The gene discussed is STAT1; the disease is central nervous system cancer.